<DOC>
	<DOCNO>NCT00498628</DOCNO>
	<brief_summary>The purpose study determine whether quetiapine fumarate extend release effective treatment alcohol dependence heavy drinker .</brief_summary>
	<brief_title>Study Effectiveness Quetiapine Treatment Alcohol Dependency</brief_title>
	<detailed_description>This study investigate quetiapine fumarate XR ( SEROQUEL XR® ) , dibenzothiazepine derivative , potential medication treat alcohol dependence . The immediate release form quetiapine fumarate , SEROQUEL XR® , approve FDA treatment schizophrenia acute manic episode associate bipolar disorder . The extended release formulation ( SEROQUEL XR® ) also approve FDA undergo clinical investigation treatment major depressive disorder , schizophrenia , generalize anxiety disorder , alcohol dependence . Treatment atypical antipsychotic clozapine olanzapine result decrease alcohol use alcohol dependent patient without comorbid psychiatric diagnosis . Quetiapine , like clozapine , appear efficacy reduce drug alcohol use among alcoholic drug dependent patient co-morbid psychiatric illness .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Between age 18 65 year old DSMIV diagnosis current alcohol dependence support SCID Module E Report `` heavy '' drinking ( 10 drink per drinking day men 8 drink per drinking day woman ) least 40 % day interval day 31 90 prior initial screen visit ( i.e . total 24 day 60day period ) , least one day `` heavy '' drink occur within last 2 week screen Seeking treatment alcohol dependence desire reduction cessation drink Able verbalize understanding consent form , able provide write informed consent , verbalize willingness complete study procedure Females child bear potential must agree use least one approve method birth control , must surgically sterile postmenopausal Able take oral medication , willing adhere medication regimen , willing return regular visit Able understand write oral instruction English complete questionnaire require protocol Can complete psychological assessment require screen baseline Able provide evidence stable residence last 2 month prior randomization , reasonable transportation arrangement study site , plan move within next 3 month unresolved legal problem ; must provide contact information family member , spouse , significant contact subject case miss appointment Breath alcohol concentration ( BAC ) equal 0.00 s/he sign informed consent document Must absolute neutrophil count 1.5 x 109/L great . Please contact site additional information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol dependence</keyword>
	<keyword>Quetiapine</keyword>
</DOC>